KAYLA YUSKA: Open Payments
NPI 1134648280 · HILLIARD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$211 in 11 payments from 10 companies in 2025. Trend: 2023 $813 · 2024 $363 · 2025 $211
Food & beverage: $211
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Corium, LLC | 1 | $29 |
| Alkermes, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Neos Therapeutics, LP | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $14 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: COBENFY, Azstarys, ARISTADA, TRINTELLIX, Adzenys XR-ODT, VRAYLAR, Relexxii, FANAPT.
Industry payments across OH — which companies pay providers there.
